Oxygen Reserve Index, a New Method of Monitoring Oxygenation Status: What Do We Need to Know?
The oxygen reserve index (ORI) is an innovative technology designed to provide real-time, non-invasive, and continuous monitoring of a patient’s oxygenation status. This new parameter has the potential to revolutionize the way clinicians assess and manage oxygenation, particularly in critical care, oxygen therapy, and intraoperative settings. This article delves into the clinical utility, prospects, and limitations of ORI, based on a comprehensive review of existing literature.
Introduction to Oxygenation Status
Oxygenation status in arterial blood is typically classified into three categories: hypoxia (PaO2: 0–80 mmHg), normoxia (PaO2: 81–100 mmHg), and hyperoxia (PaO2 > 100 mmHg). Hyperoxia is further subdivided into mild (PaO2: 101–200 mmHg) and severe (PaO2 > 200 mmHg), with some researchers adding a moderate category (PaO2: 200–299 mmHg). Mild hyperoxia, particularly in the range of 100 to 200 mmHg, is notable because it enriches the body with oxygen without posing significant risks, and it has been associated with lower mortality rates. This range of PaO2 is referred to as the oxygen reserve, which forms the basis of the oxygen reserve index (ORI).
The Concept of Oxygen Reserve Index
ORI is a dimensionless index ranging from 0 to 1, reflecting the oxygenation status in the mild hyperoxia range (PaO2: 100–200 mmHg). It was introduced as a non-invasive alternative to arterial blood gas analysis (aBGA), which is invasive and intermittent. ORI is derived from changes in mixed venous oxygen saturation (SvO2) after arterial oxygen saturation (SaO2) reaches 100%. These changes are detected using Masimo Rainbow Signal Extraction Technology, which measures the absorption of incident light as PaO2 increases. ORI is sensitive to PaO2 changes within the 100 to 200 mmHg range, providing clinicians with valuable insights into a patient’s oxygenation reserve.
Correlation Between ORI and PaO2
ORI scores correlate positively with PaO2 levels within the 100 to 200 mmHg range. Regression analysis has shown a stronger correlation between ORI and PaO2 at PaO2 ≤ 240 mmHg (r² = 0.536) compared to PaO2 > 240 mmHg (r² = 0.0016). This indicates that ORI is a reliable indicator of oxygenation status in the mild hyperoxia range but loses its predictive value in severe hyperoxia. Specifically, an ORI score > 0.24 suggests PaO2 ≥ 100 mmHg, while an ORI score > 0.55 indicates PaO2 ≥ 150 mmHg in 96.6% of cases.
Comparison of Oxygenation Monitoring Methods
Several methods are available for monitoring oxygenation, each with its advantages and limitations:
- Pulse Oximetry: This non-invasive method provides continuous monitoring of SpO2 but is limited to the range of 0 to 100 mmHg. It cannot detect changes in PaO2 before SpO2 begins to decline, making it a late indicator of hypoxia.
- Blood Gas Analysis (BGA): Considered the gold standard for measuring PaO2, BGA is invasive and often intermittent. Continuous intra-arterial BGA has been introduced but is not practical for real-time monitoring.
- Oxygen Reserve Index (ORI): ORI complements pulse oximetry by extending the range of non-invasive monitoring to 100–200 mmHg. It provides early warning of desaturation and helps clinicians avoid unnecessary hyperoxia or hypoxia.
Clinical Benefits of ORI
Early Warning for Desaturation
One of the most significant advantages of ORI is its ability to provide early warning of impending desaturation. Studies have demonstrated that ORI can predict a drop in SpO2 approximately 30 seconds before it occurs. This early warning is particularly valuable in anesthesia induction, surgery, and one-lung ventilation (OLV), where rapid desaturation can lead to severe complications. For example, in a study involving 25 children undergoing general anesthesia, ORI alerted clinicians to changes 31.5 seconds before SpO2 declined. Similarly, in adults undergoing rapid-sequence induction, ORI predicted hypoxia 30 seconds in advance.
ORI in Oxygen Therapy
Oxygen therapy is widely used in perioperative and ICU settings to prevent hypoxia. However, excessive oxygen supplementation can lead to hyperoxia, which has been associated with adverse effects on the cardiovascular, nervous, and respiratory systems. ORI, in conjunction with pulse oximetry, allows clinicians to monitor oxygenation more precisely, reducing the risk of both hypoxia and hyperoxia. For instance, a case report demonstrated the successful use of ORI to titrate FiO2 in a neonate undergoing tracheoesophageal fistula repair, maintaining an ORI score between 0 and 0.3 while keeping SpO2 above 97%.
ORI in Preoxygenation
Preoxygenation is a standard procedure before general anesthesia and endotracheal intubation, aimed at increasing oxygen stores and prolonging safe apnea time. However, traditional methods may not achieve adequate preoxygenation in obese or critically ill patients. ORI can help identify unsuccessful preoxygenation by indicating whether PaO2 has reached the desired level. An ORI score > 0.24 suggests PaO2 ≥ 100 mmHg, while a score > 0.55 indicates PaO2 ≥ 150 mmHg. This information can guide clinicians in adjusting ventilation strategies to ensure effective preoxygenation.
Influence of Indigo Carmine on ORI
Indigo Carmine, a blue dye used in urologic and gynecologic procedures, has been found to interfere with ORI measurements. Intravenous injection of Indigo Carmine causes a rapid decrease in ORI scores, often to 0, due to its peak light absorption at 620 nm, which is close to the wavelength used for ORI recording. This interference is transient, with ORI scores typically returning to baseline within 20 minutes. Clinicians should be aware of this effect to avoid misinterpreting ORI changes as hypoxia during procedures involving Indigo Carmine.
Limitations and Future Directions
Despite its promising applications, ORI is a relatively new technology with limited clinical evidence. Its utility in various settings, such as the ICU, requires further validation through high-quality studies. Additionally, the potential interference of other dyes and lights in ORI measurements needs to be explored. As research continues, ORI has the potential to provide new insights into physiology and pathophysiology, improving the monitoring and treatment of patients in critical care and other settings.
Conclusion
The oxygen reserve index (ORI) represents a significant advancement in the non-invasive monitoring of oxygenation status. By providing early warning of desaturation and extending the range of real-time monitoring to 100–200 mmHg, ORI helps clinicians avoid unnecessary hyperoxia and unexpected hypoxia. Its applications in oxygen therapy, preoxygenation, and intraoperative monitoring demonstrate its potential to improve patient outcomes. However, further research is needed to fully establish its clinical utility and address its limitations. As the technology evolves, ORI is poised to become an essential tool in the management of oxygenation in various medical settings.
doi.org/10.1097/CM9.0000000000000625
Was this helpful?
0 / 0